Home > Insider Trading > Filing (0001209191-10-015131)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879993	Dusa Pharmaceuticals Inc	DUSA	Pharmaceutical Preparations (2834)	223103129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1138558	M Jay Haft	110 East 57Th Street Suite 14A New York NY 10022		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-03-05	10,000	$1.72	25,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	34,500	Indirect	by wife

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.68010 to $1.75010, inclusive. The reporting person undertakes to provide to DUSA Pharmaceuticals, Inc., any security holder of DUSA Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Includes Stock Awards which vest at the rate of one-quarter of the total grant on each of the first, second, third and fourth anniversaries of the date of the grant.